Kevin M. Alexander, MD
Kevin M. Alexander, MD
Dr. Alexander is a heart failure specialist and Assistant Professor of Cardiovascular Medicine at Stanford University. He treats complex heart failure and transplant patients and leads a research lab focused on advancing care for underrecognized conditions like transthyretin cardiac amyloidosis. His work is supported by the NIH and American Heart Association.
Articles by Kevin M. Alexander, MD
MITT and safety data show acoramidis significantly lowers AFib-related events in transthyretin cardiac amyloidosis.
ESC 2025: Acoramidis may reduce AF/flutter burden in ATTR-CM, per new ATTRibute-CM trial analysis discussed by CardioNerds.
Dr. Kevin Alexander speaks with The CardioNerds about the importance of providing swift treatment to patients with ATTR-CM.
The CardioNerds, Dr. Alexander discuss how acoramidis therapy works, and details data Dr. Alexander presented at AHA 2024.
Dr. Georgia Vasilakis Tsatiris of The CardioNerds speaks to Dr. Kevin Alexander about the impact of ATTR-CM.
The CardioNerds and Dr. Alexander discuss the findings of the ATTRibute-CM clinical trial.
The CardioNerds and Dr. Alexander analyze biomarkers in ATTR-CM.
The CardioNerds and Dr. Kevin M. Alexander discuss the nuances of transthyretin amyloid cardiomyopathy.
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.